Growing Geriatric Population and Higher Prevalence to Propel Respiratory Disease Testing Market to USD 2.7 Billion by 2020

Growing Geriatric Population and Higher Prevalence to Propel Respiratory Disease Testing Market to USD 2.7 Billion by 2020

The global respiratory disease testing market is estimated to reach USD 2.7 Billion in 2020, growing at a CAGR of 4.2% from 2016 to 2020, according to a new market research report Respiratory Disease Testing Market – Global Diagnostics and End Users Analysis and Forecast 2016-2020, published by iHealthcareAnalyst, Inc.

Visit the Respiratory Disease Testing Market – Global Diagnostics and End Users Analysis and Forecast 2016-2020 report at https://www.ihealthcareanalyst.com/report/respiratory-disease-testing-market/

The main clinical respiratory function tests include diagnosis, assessment of severity, monitoring treatment and evaluation of prognosis. Many physicians opt for blood gases to evaluate oxygen and carbon dioxide levels, lung or pulmonary function tests (PFTs) to help diagnose and monitor lung function, and chest X-rays and or CT (computed tomography) scans to look at lung structure. The global respiratory disease testing market report estimates the market size (Revenue USD million – 2013 to 2020) for market segmentation based on diagnostic tests such as blood gas tests, imaging tests, lung volume tests, peak flow tests, spirometry tests, CBC and CMP tests along with their end users (clinical laboratories, hospitals and physician office), and forecasts growth trends (CAGR% – 2016 to 2020). It also provides the detailed market landscape and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent acquisitions and alliances.

The global respiratory disease testing market is segmented as:

  1. Diagnostic Test
    • Blood Gas Tests
    • Imaging Tests
    • Lung Volume Tests
    • Peak Flow Tests
    • Spirometry Tests
    • Other Tests (Complete Blood Count, Comprehensive Metabolic Panel, etc.)
  1. End User
    • Clinical Laboratories
    • Hospitals
    • Physician Offices
  1. Geography (Region, Country)
    • North America (U.S., Canada)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Rest of the World
  1. Company Profiles
    • CareFusion Corporation
    • Carestream Health, Inc.
    • Cosmed
    • Futuremed America, Inc.
    • GE Healthcare
    • MGC Diagnostics Corporation
    • ndd Medical Technologies, Inc.
    • Nihon Kohden Corporation
    • Perkin Elmer, Inc.
    • Philips Healthcare
    • SDI Diagnostics
    • Siemens Healthcare
    • Smiths Medical

About Us

iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.

Contact Us

iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: [email protected]
Website: https://www.ihealthcareanalyst.com

2016-10-14T06:19:42+00:00 Categories: Press Releases|
Translate »